Pharmacy-to-dose renal adjustment for common antimicrobials
Use as a template
Sign in and create or join an organization to copy this protocol into it as a draft.
ClinDose template, review and adapt before use
Pharmacists may adjust doses of the antimicrobials below for kidney function. Doses are quoted from each FDA label; review and adapt to your institution.
Piperacillin and tazobactam
| CrCl (mL/min) | Dose |
|---|---|
| Above 40 | All Indications (except nosocomial pneumonia): 3.375 g every 6 hours; Nosocomial Pneumonia: 4.5 g every 6 hoursFDA label |
| 20 to 40 | All Indications (except nosocomial pneumonia): 2.25 g every 6 hours; Nosocomial Pneumonia: 3.375 g every 6 hoursFDA label |
| 0 to 19 | All Indications (except nosocomial pneumonia): 2.25 g every 8 hours; Nosocomial Pneumonia: 2.25 g every 6 hoursFDA label |
Cefepime
| CrCl (mL/min) | Dose |
|---|---|
| Above 60 | Recommended Maintenance Schedule: 500 mg every 12 hours; 1 g every 12 hours; 2 g every 12 hours; 2 g every 8 hoursFDA label |
| 30 to 60 | Recommended Maintenance Schedule: 500 mg every 24 hours; 1 g every 24 hours; 2 g every 24 hours; 2 g every 12 hoursFDA label |
| 11 to 29 | Recommended Maintenance Schedule: 500 mg every 24 hours; 500 mg every 24 hours; 1 g every 24 hours; 2 g every 24 hoursFDA label |
| 0 to 10 | Recommended Maintenance Schedule: 250 mg every 24 hours; 250 mg every 24 hours; 500 mg every 24 hours; 1 g every 24 hoursFDA label |
Meropenem
| CrCl (mL/min) | Dose |
|---|---|
| Above 50 | Dose (dependent on type of infection): Recommended dose (500 mg cSSSI and 1 gram Intra-abdominal); Dosing Interval: Every 8 hoursFDA label |
| 26 to 50 | Dose (dependent on type of infection): Recommended dose; Dosing Interval: Every 12 hoursFDA label |
| 10 to 25 | Dose (dependent on type of infection): One-half recommended dose; Dosing Interval: Every 12 hoursFDA label |
| 0 to 9 | Dose (dependent on type of infection): One-half recommended dose; Dosing Interval: Every 24 hoursFDA label |
Levofloxacin
| CrCl (mL/min) | Dose |
|---|---|
| 50 and above | Usual dose for the indicationPlaceholder |
| 20 to 49 | 750 mg every 24 hours: 750 mg every 48 hours; 500 mg every 24 hours: 500 mg initial dose, then 250 mg every 24 hours; 250 mg every 24 hours: No dosage adjustment requiredFDA label |
| 10 to 19 | 750 mg every 24 hours: 750 mg initial dose, then 500 mg every 48 hours; 500 mg every 24 hours: 500 mg initial dose, then 250 mg every 48 hours; 250 mg every 24 hours: 250 mg every 48 hours. If treating uncomplicated UTI, then no dosage adjustment is requiredFDA label |
Ciprofloxacin
Ampicillin and sulbactam
| CrCl (mL/min) | Dose |
|---|---|
| 30 and above | Recommended Ampicillin and Sulbactam for Injection Dosage: 1.5 g to 3 g every 6 to 8 hoursFDA label |
| 15 to 29 | Recommended Ampicillin and Sulbactam for Injection Dosage: 1.5 g to 3 g every 12 hoursFDA label |
| 5 to 14 | Recommended Ampicillin and Sulbactam for Injection Dosage: 1.5 g to 3 g every 24 hoursFDA label |
Fluconazole
Acyclovir
| CrCl (mL/min) | Dose |
|---|---|
| Above 50 | Percent of Recommended Dose: 100%; Dosing Interval (hours): 8FDA label |
| 25 to 50 | Percent of Recommended Dose: 100%; Dosing Interval (hours): 12FDA label |
| 10 to 24 | Percent of Recommended Dose: 100%; Dosing Interval (hours): 24FDA label |
| 0 to 9 | Percent of Recommended Dose: 50%; Dosing Interval (hours): 24FDA label |
Daptomycin
Restriction criteria
- Who can orderPharmacists, under the pharmacy-to-dose policy approved by your committee
- ApprovalNot required
- Reassess when kidney function changes
Sources
- FDA label for piperacillin and tazobactam (DailyMed), dosage in renal impairment, effective 2026-05-08
- FDA label for cefepime (DailyMed), dosage in renal impairment, effective 2026-06-25
- FDA label for meropenem (DailyMed), dosage in renal impairment, effective 2026-08-26
- FDA label for levofloxacin (DailyMed), dosage in renal impairment, effective 2026-05-22
- FDA label for ciprofloxacin (DailyMed), dosage in renal impairment, effective 2025-07-28
- FDA label for ampicillin and sulbactam (DailyMed), dosage in renal impairment, effective 2026-06-23
- FDA label for fluconazole (DailyMed), dosage in renal impairment, effective 2026-01-07
- FDA label for acyclovir (DailyMed), dosage in renal impairment, effective 2025-07-18
- FDA label for daptomycin (DailyMed), dosage in renal impairment, effective 2026-08-06